Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray Brunt, Adrian, Haviland, Joanne S, Wheatley, Duncan A, Sydenham, Mark A, Alhasso, Abdulla, Bloomfield, David J, Chan, Charlie, Churn, Mark, Cleator, Susan, Coles, Charlotte E, Goodman, Andrew, Harnett, Adrian, Hopwood, Penelope, Kirby, Anna M, Kirwan, Cliona C, Morris, Carolyn, Nabi, Zohal, Sawyer, Elinor, Somaiah, Navita, Stones, Liba, Syndikus, Isabel, Bliss, Judith M, Yarnold, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262592/
https://www.ncbi.nlm.nih.gov/pubmed/32580883
http://dx.doi.org/10.1016/S0140-6736(20)30932-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262592/
https://www.ncbi.nlm.nih.gov/pubmed/32580883
http://dx.doi.org/10.1016/S0140-6736(20)30932-6

Ejemplares similares